AVH News: AVITA Medical Announces FDA Approval of RECELL for Treatment of Full-Thickness Skin Defects - 8th Jun 2023, 10:00am

annb0t

Top 20
AVITA Medical

VALENCIA, Calif. and MELBOURNE, Australia, June 07, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announced that the U.S. Food and Drug Administration (FDA) has approved its premarket approval (PMA) supplement for the use of its RECELL® System to treat full-thickness skin defects.

“Th...

>>> Read more: AVITA Medical Announces FDA Approval of RECELL for Treatment of Full-Thickness Skin Defects
 
Top Bottom